BFLY
Butterfly Network, Inc. Health Care X-Ray Apparatus & Tubes & Related Irradiation Apparatus Russell 3000
$6.39Close
$1.97 – $9.9352-week range
Jan 28, 2027Next report · estimated
Highlights
Strengths
- Leading the market RS 92 · stronger than 92% of stocks over 12 months
Cautions
- Not in an uptrend 5 of 8 trend conditions
- Far from its high 36% below its 52-week high
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
36%
1wk
down 5.5%
price change
1mo
down 28.7%
price change
12-month return
up 213%
market up 11% ·
its own up 186%
F-score
—
— Not assessed
Altman Z
—
Unknown
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
—
price / book
Earnings yield
—
EBIT / enterprise value
Cheaper than
—
of the market · not assessed
Revenue growth
up 19%
year on year
EPS growth
—
latest quarter
Sales growth
up 52%
latest quarter · +12 pts
ROE
down 42%
return on equity
Free cash margin
down 16%
-$16.0M FCF
D/E
—
long-term debt / equity
Net debt / EBITDA
—
Interest cover
—EBIT / interest
Trade setup
ATR%
9.9%
$0.63 a day · 2×ATR $5.12
RS
92 / 99
vs the universe
Trend
5 / 8
under the 150/200-day, under the 50-day, over 25% off the high
Relative volume
1.5×
vs 50-day average
Up/down volume
0.73
50 sessions
Implied move
—
no scheduled report
Trend template · 5 of 8
- Price above the 150 and 200-day averages: fails
- 150-day average above the 200-day: passes
- 200-day average rising for a month: passes
- 50-day average above the 150 and 200-day: passes
- Price above the 50-day average: fails
- At least 30% above the 52-week low: passes
- Within 25% of the 52-week high: fails
- RS rank 70 or higher: passes
Screen verdict
Did not qualify for any screen.
Warning signs
- Gross margin narrowing Gross margin fell from 59.5% to 46.9%. The company is keeping less of each dollar of sales than it did a year ago.
Last reported
Oct 29, 2026
Results reaction
Oct 29, 2026-16% vs market2 sessions after results
Financials
- Gross 47%
- Net -79%
- Free cash -16%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $46.3M | $62.6M | $73.4M | $65.9M | $82.1M | $97.6M |
| Gross margin | -132% | 27% | 54% | 26% | 60% | 47% |
| Operating income | -$161.6M | -$192.7M | -$193.0M | -$145.6M | -$74.4M | -$86.4M |
| Net income | -$162.7M | -$32.4M | -$168.7M | -$133.7M | -$72.5M | -$77.1M |
| Net margin | -352% | -52% | -230% | -203% | -88% | -79% |
| Earnings per share | -$26.87 | -$0.19 | -$0.84 | -$0.65 | -$0.34 | -$0.31 |
| Free cash flow | -$84.1M | -$197.1M | -$187.4M | -$104.6M | -$44.4M | -$16.0M |
| Free cash margin | -182% | -315% | -255% | -159% | -54% | -16% |
| Cash | $60.2M | $422.8M | $162.6M | $134.4M | $88.8M | $150.5M |
| Long-term debt | $4.4M | — | — | — | — | — |
| Shareholders' equity | -$361.9M | $447.7M | $325.4M | $220.1M | $168.8M | $196.0M |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Oct 29, 2026 | Quarterly ↗ | Sep 30, 2026 | 29d |
| Jul 30, 2026 | Quarterly ↗ | Jun 30, 2026 | 30d |
| Apr 30, 2026 | Quarterly ↗ | Mar 31, 2026 | 30d |
| Feb 27, 2026 | Annual ↗ | Dec 31, 2025 | 58d |
| Oct 31, 2025 | Quarterly ↗ | Sep 30, 2025 | 31d |
| Aug 1, 2025 | Quarterly ↗ | Jun 30, 2025 | 32d |
| May 2, 2025 | Quarterly ↗ | Mar 31, 2025 | 32d |
| Feb 28, 2025 | Annual ↗ | Dec 31, 2024 | 59d |
| Nov 1, 2024 | Quarterly ↗ | Sep 30, 2024 | 32d |
| Aug 1, 2024 | Quarterly ↗ | Jun 30, 2024 | 32d |
| May 1, 2024 | Quarterly ↗ | Mar 31, 2024 | 31d |
| Mar 4, 2024 | Annual ↗ | Dec 31, 2023 | 64d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 29, 2026 | Results ↗ |
| Oct 5, 2026 | Director or officer change ↗ |
| Aug 11, 2026 | Director or officer change ↗ |
| Jul 30, 2026 | Results ↗ |
| Jun 22, 2026 | Shareholder vote ↗ |
| May 8, 2026 | Director or officer change ↗ |
| Apr 30, 2026 | Results ↗ |
| Feb 26, 2026 | Results ↗ |
| Jan 14, 2026 | Listing notice ↗ |
| Jan 12, 2026 | Results ↗ |
| Nov 18, 2025 | Material agreement ↗ |
| Oct 31, 2025 | Results ↗ |